Search

Search Constraints

You searched for: Author/Creator Thuluvath, Paul

Search Results

1. A Karnofsky performance status–based score predicts death after hospital discharge in patients with cirrhosis. Issue 1 (29th November 2016)

2. Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis. Issue 5 (8th July 2021)

4. Human bile contains MicroRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Issue 3 (25th July 2014)

5. NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis. Issue 6 (19th April 2018)

6. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

7. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

8. Outcomes After Listing for Liver Transplant in Patients With Acute‐on‐Chronic Liver Failure: The Multicenter North American Consortium for the Study of End‐Stage Liver Disease Experience. Issue 4 (24th March 2019)

9. Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort. (April 2018)

10. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)